Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:125-132

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knight, C. J.
Right arrow Articles by Goodall, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knight, C. J.
Right arrow Articles by Goodall, A. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMLODIPINE BESYLATE
*ATENOLOL
*NITROGLYCERIN

(Circulation. 1997;95:125-132.)
© 1997 American Heart Association, Inc.


Articles

Different Effects of Calcium Antagonists, Nitrates, and ß-Blockers on Platelet Function

Possible Importance for the Treatment of Unstable Angina

Charles J. Knight, MRCP; Manvinder Panesar, BSc; Darren J. Wilson, MSc; Nicolas A.F. Chronos, MRCP; Deven Patel, MRCP; Kim Fox, MD; Alison H. Goodall, PhD

the Department of Cardiology, Royal Brompton Hospital, (C.J.K., N.A.F.C., D.P., K.F.) and the Vascular Cell Biology Laboratory, Royal Free Hospital School of Medicine (M.P., D.J.W., A.H.G.), London, UK.

Correspondence to Dr Alison Goodall, Vascular Cell Biology Laboratory, Royal Free Hospital School of Medicine, Rowland Hill St, London NW3 2PF, UK.

Background The three major classes of antianginal drug all inhibit platelet aggregation at high concentrations in vitro, but detecting clinically relevant effects has proved to be more difficult. We used whole-blood flow cytometry, a sensitive method that allows direct measurement of activation antigens on the surface of individual platelets in whole unfixed blood, to evaluate the effect of representative antianginal drugs on platelet function in vivo in healthy volunteers.

Methods and Results The effects of glyceryl trinitrate (GTN), amlodipine, and atenolol were studied in nine normal volunteers. Fibrinogen binding to activated GP IIb/IIIa and expression of P-selectin, GP Ib, and GP IIb/IIIa on the platelet surface were measured. In addition, fibrinogen binding and P-selectin expression were measured in response to ex vivo stimulation with the agonists ADP and thrombin. The three drugs had very different effects on platelets. GTN inhibited platelet fibrinogen binding and expression of P-selectin at rest and in response to agonist stimulation, whereas amlodipine enhanced P-selectin expression and atenolol increased fibrinogen binding in response to agonists. Atenolol did not block the stimulatory effects of epinephrine on ADP-induced platelet activation. GTN neutralized the proactivatory effects of amlodipine, whereas the effects of atenolol and amlodipine were not additive.

Conclusions The three main classes of antianginal medication have different and possible clinically relevant effects on platelet behavior in vivo, nitrates causing inhibition of aggregation (fibrinogen binding) and degranulation (P-selectin expression), calcium antagonists enhancing degranulation, and ß-blockers enhancing aggregation.


Key Words: platelets • drugs • angina




This article has been cited by other articles:


Home page
Eur Heart JHome page
I. Chung and G. Y.H. Lip
Platelets and heart failure
Eur. Heart J., November 2, 2006; 27(22): 2623 - 2631.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
H Dai, J Chen, Q Tao, J Zhu, F Zhang, L Zheng, and Y Qiu
Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty
Postgrad. Med. J., September 1, 2003; 79(935): 522 - 526.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. D. Blann, S. Nadar, and G. Y.H. Lip
Pharmacological Modulation of Platelet Function in Hypertension
Hypertension, July 1, 2003; 42(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Haramaki, H. Ikeda, Y. Takajo, A. Katoh, S. Kanaya, S. Shintani, R. Haramaki, T. Murohara, and T. Imaizumi
Long-Term Smoking Causes Nitroglycerin Resistance in Platelets by Depletion of Intraplatelet Glutathione
Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1852 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Bihour, C. Durrieu-Jais, L. Macchi, C. Poujol, P. Coste, P. Besse, P. Nurden, and A. T. Nurden
Expression of Markers of Platelet Activation and the Interpatient Variation in Response to Abciximab
Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 212 - 219.
[Abstract] [Full Text] [PDF]